KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Other Non-Current Assets (2016 - 2026)

Bristol Myers Squibb has reported Other Non-Current Assets over the past 18 years, most recently at $6.1 billion for Q1 2026.

  • Quarterly Other Non-Current Assets rose 3.68% to $6.1 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.1 billion through Mar 2026, up 3.68% year-over-year, with the annual reading at $6.5 billion for FY2025, 6.04% up from the prior year.
  • Other Non-Current Assets was $6.1 billion for Q1 2026 at Bristol Myers Squibb, down from $6.5 billion in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $6.5 billion in Q4 2025 and troughed at $53.0 million in Q1 2023.
  • The 5-year median for Other Non-Current Assets is $5.9 billion (2025), against an average of $3.9 billion.
  • Year-over-year, Other Non-Current Assets crashed 97.06% in 2022 and then soared 11354.72% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $4.9 billion in 2022, then increased by 8.7% to $5.4 billion in 2023, then rose by 13.69% to $6.1 billion in 2024, then increased by 6.04% to $6.5 billion in 2025, then fell by 6.05% to $6.1 billion in 2026.
  • Per Business Quant, the three most recent readings for BMY's Other Non-Current Assets are $6.1 billion (Q1 2026), $6.5 billion (Q4 2025), and $6.3 billion (Q3 2025).